9342 8530 Qubec Stock Current Asset
9342 8530 Qubec fundamentals help investors to digest information that contributes to 9342-8530 Qubec's financial success or failures. It also enables traders to predict the movement of 9342-8530 Stock. The fundamental analysis module provides a way to measure 9342-8530 Qubec's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to 9342-8530 Qubec stock.
9342-8530 |
9342 8530 Qubec Company Current Asset Analysis
9342-8530 Qubec's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current 9342-8530 Qubec Current Asset | 741 K |
Most of 9342-8530 Qubec's fundamental indicators, such as Current Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, 9342 8530 Qubec is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
CompetitionIn accordance with the recently published financial statements, 9342 8530 Qubec has a Current Asset of 741 K. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The current asset for all United States stocks is notably lower than that of the firm.
9342-8530 Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses 9342-8530 Qubec's direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of 9342-8530 Qubec could also be used in its relative valuation, which is a method of valuing 9342-8530 Qubec by comparing valuation metrics of similar companies.9342 8530 is currently under evaluation in current asset category among its peers.
9342-8530 Fundamentals
| Return On Equity | 1.28 | |||
| Return On Asset | 1.34 | |||
| Profit Margin | 0.41 % | |||
| Operating Margin | 0.77 % | |||
| Current Valuation | (392.06 K) | |||
| Shares Outstanding | 43.04 M | |||
| Price To Sales | 0 X | |||
| Revenue | 515.37 K | |||
| Gross Profit | 117.96 K | |||
| EBITDA | 5.46 M | |||
| Net Income | (3.6 M) | |||
| Cash And Equivalents | 392.49 K | |||
| Cash Per Share | 0.01 X | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 3.74 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (1.17 M) | |||
| Earnings Per Share | 0.05 X | |||
| Beta | 0.98 | |||
| Market Capitalization | 43 | |||
| Total Asset | 1.79 M | |||
| Retained Earnings | (74.97 M) | |||
| Working Capital | 465 K | |||
| Current Asset | 741 K | |||
| Current Liabilities | 276 K | |||
| Z Score | -47.5 | |||
| Net Asset | 1.79 M |
About 9342-8530 Qubec Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze 9342 8530 Qubec's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 9342-8530 Qubec using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 9342 8530 Qubec based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Consideration for investing in 9342-8530 Stock
If you are still planning to invest in 9342 8530 Qubec check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the 9342-8530 Qubec's history and understand the potential risks before investing.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |